⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL3292218 | 0.89 | — | — | |
| Dioxane SCHEMBL4414289 | 0.85 | ALDH1A1 (0.50) | — | |
| Dioxane SCHEMBL27710851 | 0.81 | ALDH1A1 (0.46) | — | |
| Dioxane SCHEMBL8207440 | 0.81 | ALDH1A1 (0.46) | — | |
| Oxirane SCHEMBL27595280 | 0.81 | — | — | |
| Methyl Alcohol SCHEMBL3181443 | 0.81 | — | — | |
| Dioxane SCHEMBL2057757 | 0.79 | TTR (0.43) | — | |
| Oxirane SCHEMBL7653670 | 0.77 | — | — | |
| Ethane SCHEMBL25281911 | 0.76 | — | — | |
| SCHEMBL8123592 | 0.76 | TSHR (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1843805-A2 | ANTIMICROBIAL NEEDLE COATING FOR EXTENDED INFUSION | Angiotech BioCoatings, Corp. (US) | 2007-10-17 | — | — | EP | claimed |
| WO-2006053007-A2 | ANTIMICROBIAL NEEDLE COATING FOR EXTENDED INFUSION | ANGIOTECH BIOCOATINGS CORP. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20070299409-A1 | Antimicrobial Needle Coating For Extended Infusion | ANGIOTECH BIOCOATINGS CORP. (US) | 2007-12-27 | — | — | US | disclosed |
| EP-1843805-A2 | ANTIMICROBIAL NEEDLE COATING FOR EXTENDED INFUSION | Angiotech BioCoatings, Corp. (US) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006053007-A2 | ANTIMICROBIAL NEEDLE COATING FOR EXTENDED INFUSION | ANGIOTECH BIOCOATINGS CORP. (US) | 2006-05-18 | — | — | WO | disclosed |